EXL Board of Directors Appoints Rohit Kapoor Board Chair; Announces other Board and Management Changes
Kapoor becomes chair in addition to his current role as chief executive officer; Vikram Pandit to transition to lead independent […]
TSX News -
Stack Capital Holding Prove Identity Announces Strategic Partnership with BetMGM
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Prove […]
Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
REYKJAVIK, Iceland, April 03, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and […]
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
LONDON, April 03, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical […]
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (NASDAQ: ORGO) a leading regenerative medicine company focused on […]
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of […]
National Spotlight Features Phio’s Innovative RNAi Technology Platform
—Program will be airing on PBS with Dennis Quaid in April —It will also be seen on Fox Business Network […]
Brixton Metals Reports Best Copper-Gold-Silver Results to Date from the Hog Heaven Project
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) […]
Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update
MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]
Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference
MORRISTOWN, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to pushing […]
